People news

Share this article:
Oscient Pharmaceuticals has announced that Dominick Colangelo, executive vice president, corporate development & operations, will resign his current position, effective immediately. Colangelo will stay on with the company as a consultant until Jan. 31, 2009. The resultant corporate team at Oscient will consist of Steve Rauscher, CEO and president, Philippe Maitre, EVP and chief financial officer, and Mark Glickman, SVP, sales and marketing.
Neogenix Oncology has announced the appointment of Ted Sorensen as vice chairman. Sorensen is currently a counsel member as US law firm Paul, Weiss, Fifkind, Wharton & Garrison, and was formerly special counsel and adviser to President John F. Kennedy.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.